Literature DB >> 33737894

Neuropsychiatric and Cognitive Sequelae of COVID-19.

Sanjay Kumar1, Alfred Veldhuis1, Tina Malhotra2.   

Abstract

Coronavirus disease 2019 (COVID-19) is likely to have long-term mental health effects on individuals who have recovered from COVID-19. Rightly, there is a global response for recognition and planning on how to deal with mental health problems for everyone impacted by the global pandemic. This does not just include COVID-19 patients but the general public and health care workers as well. There is also a need to understand the role of the virus itself in the pathophysiology of mental health disorders and longer-term mental health sequelae. Emerging evidence suggests that COVID-19 patients develop neurological symptoms such as headache, altered consciousness, and paraesthesia. Brain tissue oedema and partial neurodegeneration have also been observed in an autopsy. In addition, there are reports that the virus has the potential to cause nervous system damage. Together, these findings point to a possible role of the virus in the development of acute psychiatric symptoms and long-term neuropsychiatric sequelae of COVID-19. The brain pathologies associated with COVID-19 infection is likely to have a long-term impact on cognitive processes. Evidence from other viral respiratory infections, such as severe acute respiratory syndrome (SARS), suggests a potential development of psychiatric disorders, long-term neuropsychiatric disorders, and cognitive problems. In this paper, we will review and evaluate the available evidence of acute and possible long-term neuropsychiatric manifestations of COVID-19. We will discuss possible pathophysiological mechanisms and the implications this will have on preparing a long-term strategy to monitor and manage such patients.
Copyright © 2021 Kumar, Veldhuis and Malhotra.

Entities:  

Keywords:  cognition; coronavirus disease 2019; depression; mental health; neuropsychiatric disease

Year:  2021        PMID: 33737894      PMCID: PMC7960660          DOI: 10.3389/fpsyg.2021.577529

Source DB:  PubMed          Journal:  Front Psychol        ISSN: 1664-1078


  25 in total

Review 1.  Legacy of neuropsychiatric symptoms associated with past COVID-19 infection: A cause of concern.

Authors:  Domenico De Berardis; Francesco Di Carlo; Massimo Di Giannantonio; Mauro Pettorruso
Journal:  World J Psychiatry       Date:  2022-06-19

2.  Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic.

Authors:  Ronald C Kessler; Christopher J Ruhm; Victor Puac-Polanco; Irving H Hwang; Sue Lee; Maria V Petukhova; Nancy A Sampson; Hannah N Ziobrowski; Alan M Zaslavsky; Jose R Zubizarreta
Journal:  JAMA Netw Open       Date:  2022-06-01

Review 3.  Neuropsychiatric Disorders and COVID-19: What We Know So Far.

Authors:  Fernanda Majolo; Guilherme Liberato da Silva; Lucas Vieira; Cetin Anli; Luís Fernando Saraiva Macedo Timmers; Stefan Laufer; Márcia Inês Goettert
Journal:  Pharmaceuticals (Basel)       Date:  2021-09-17

Review 4.  Dysregulation in erythrocyte dynamics caused by SARS-CoV-2 infection: possible role in shuffling the homeostatic puzzle during COVID-19.

Authors:  Michelle Mendanha Mendonça; Kellen Rosa da Cruz; Denise da Silva Pinheiro; Gean Carlos Alves Moraes; Patricia Maria Ferreira; Marcos Luiz Ferreira-Neto; Eduardo Sérgio da Silva; Reggiani Vilela Gonçalves; Gustavo Rodrigues Pedrino; James O Fajemiroye; Carlos Henrique Xavier
Journal:  Hematol Transfus Cell Ther       Date:  2022-01-25

Review 5.  Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review).

Authors:  Vasiliki Efstathiou; Maria-Ioanna Stefanou; Nikolaos Siafakas; Michael Makris; Georgios Tsivgoulis; Vassilios Zoumpourlis; Demetrios A Spandidos; Nikolaos Smyrnis; Emmanouil Rizos
Journal:  Exp Ther Med       Date:  2021-12-02       Impact factor: 2.447

Review 6.  Coronavirus persistence in human respiratory tract and cell culture: An overview.

Authors:  Adriana Gaspar-Rodríguez; Ana Padilla-González; Evelyn Rivera-Toledo
Journal:  Braz J Infect Dis       Date:  2021-10-02       Impact factor: 3.257

Review 7.  Post-COVID-19 Syndrome and the Potential Benefits of Exercise.

Authors:  Amaya Jimeno-Almazán; Jesús G Pallarés; Ángel Buendía-Romero; Alejandro Martínez-Cava; Francisco Franco-López; Bernardino J Sánchez-Alcaraz Martínez; Enrique Bernal-Morel; Javier Courel-Ibáñez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

Review 8.  COVID-19-induced pulmonary sarcoid: A case report and review of the literature.

Authors:  Kathleen M Capaccione; Claire McGroder; Christine Kim Garcia; Sean Fedyna; Anjali Saqi; Mary M Salvatore
Journal:  Clin Imaging       Date:  2022-01-13       Impact factor: 1.605

Review 9.  Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19.

Authors:  Angel Yun-Kuan Thye; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Priyia Pusparajah; Hooi-Leng Ser; Sivakumar Thurairajasingam; Vengadesh Letchumanan; Learn-Han Lee
Journal:  Biology (Basel)       Date:  2022-01-02

10.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.